A history of expedited pathways: Breakthrough therapy designation, PRIME, Sakigake, and ILAP
RF QuarterlyMaurice Bancsi, PhD
AsiaEuropeMedical DevicesNorth AmericaPharmaceuticalsRF QuarterlyMaurice Bancsi, PhDAsiaEuropeMedical DevicesNorth AmericaPharmaceuticals